RxDoctor Payments Data

Hossein Sadeghi

Pediatric Pulmonology · Stamford, CTNPI 1063423028

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,844 of the $2,746 with a category attached, or 67.1%. 23 manufacturers reported payments, led by Gilead at 26.8% of the total.

$2,746in general payments, 2019–2025

Across 62 payments — averaging $44.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$735
  • Coloplast$555
  • Mylan Specialty L.p.$288
  • Viatris Specialty LLC$175
  • AstraZeneca$124
  • AbbVie$115
  • plus $754 from 17 others
$53,796in research payments, 2019–2025

Across 3 payments — averaging $17,932 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astrazeneca UK Limited$45K
  • Vertex$9K

What the payments were for

  • Consulting fees$68825%
  • Food & beverage$1,84467%
  • Education$2158%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric pulmonology providers in Connecticutto place this figure against a meaningful peer group, so we don't.

Other pediatric pulmonology in Stamford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →